Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Poised to address unmet need in neuromuscular diseases and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Dec 23, 2025
Document Date
Dec 22, 2025
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.
Filer
Karnani Vikram